↓ Skip to main content

Phase I study of recombinant human tumor necrosis factor

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, September 1987
Altmetric Badge

Mentioned by

patent
2 patents

Citations

dimensions_citation
124 Dimensions

Readers on

mendeley
24 Mendeley
Title
Phase I study of recombinant human tumor necrosis factor
Published in
Cancer Chemotherapy and Pharmacology, September 1987
DOI 10.1007/bf00570490
Pubmed ID
Authors

Kiyoji Kimura, Tetsuo Taguchi, Ichiro Urushizaki, Ryuzo Ohno, Osahiko Abe, Hisashi Furue, Takao Hattori, Hidehito Ichihashi, Kiyoshi Inoguchi, Hisashi Majima, Hisanobu Niitani, Kazuo Ota, Tatsuo Saito, Shoji Suga, Yozo Suzuoki, Akira Wakui, Kazumasa Yamada, The A-TNF Cooperative Study Group

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 24 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 25%
Student > Ph. D. Student 5 21%
Student > Bachelor 4 17%
Student > Master 2 8%
Student > Doctoral Student 1 4%
Other 1 4%
Unknown 5 21%
Readers by discipline Count As %
Agricultural and Biological Sciences 6 25%
Medicine and Dentistry 4 17%
Biochemistry, Genetics and Molecular Biology 3 13%
Sports and Recreations 1 4%
Immunology and Microbiology 1 4%
Other 2 8%
Unknown 7 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 October 2017.
All research outputs
#8,535,472
of 25,374,647 outputs
Outputs from Cancer Chemotherapy and Pharmacology
#728
of 2,561 outputs
Outputs of similar age
#3,452
of 11,520 outputs
Outputs of similar age from Cancer Chemotherapy and Pharmacology
#1
of 5 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,561 research outputs from this source. They receive a mean Attention Score of 4.5. This one is in the 31st percentile – i.e., 31% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 11,520 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 8th percentile – i.e., 8% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them